TreeWAS – Variant ID: rs12526453

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.000	1.000
I25.2 Old myocardial infarction	0.000	0.000	1.000
I25.1 Atherosclerotic heart disease	0.000	0.000	1.000
I25 Chronic ischaemic heart disease	0.000	0.000	1.000
I20 Angina pectoris	0.000	0.000	1.000
I20-I25 Ischaemic heart diseases	0.000	0.000	1.000
I21 Acute myocardial infarction	0.000	0.000	1.000
I20.0 Unstable angina	0.000	0.000	1.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.001	0.999
I21.9 Acute myocardial infarction, unspecified	0.000	0.001	0.999
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.001	0.999
I20.9 Angina pectoris, unspecified	0.000	0.003	0.997
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.003	0.997
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.005	0.995
I22 Subsequent myocardial infarction	0.000	0.008	0.992
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.018	0.982
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.043	0.957
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.118	0.882
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.118	0.882
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.147	0.853
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.158	0.842
I22.8 Subsequent myocardial infarction of other sites	0.000	0.172	0.828
I25.3 Aneurysm of heart	0.000	0.173	0.827
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.239	0.761
Z95.3 Presence of xenogenic heart valve	0.000	0.245	0.755
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.247	0.753
I25.6 Silent myocardial ischaemia	0.000	0.283	0.717
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.283	0.717
I25.5 Ischaemic cardiomyopathy	0.000	0.327	0.673
I23 Certain current complications following acute myocardial infarction	0.000	0.337	0.663
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.339	0.661
I24 Other acute ischaemic heart diseases	0.000	0.420	0.580
I20.8 Other forms of angina pectoris	0.000	0.479	0.521
Z95.0 Presence of cardiac pacemaker	0.000	0.503	0.497
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.525	0.475
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.525	0.475
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.525	0.475
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.525	0.475
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.525	0.475
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.525	0.475
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.525	0.475
I24.8 Other forms of acute ischaemic heart disease	0.000	0.526	0.474
I25.4 Coronary artery aneurysm	0.001	0.553	0.446
I24.1 Dressler's syndrome	0.000	0.557	0.443
I23.8 Other current complications following acute myocardial infarction	0.000	0.579	0.421
I20.1 Angina pectoris with documented spasm	0.000	0.623	0.377
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.668	0.332
Z95.2 Presence of prosthetic heart valve	0.000	0.721	0.279
I21.4 Acute subendocardial myocardial infarction	0.000	0.753	0.247
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.792	0.208
Z95.4 Presence of other heart-valve replacement	0.000	0.844	0.156
N70.1 Chronic salpingitis and oophoritis	0.116	0.884	0.000
N76 Other inflammation of vagina and vulva	0.110	0.890	0.000
N70 Salpingitis and oophoritis	0.110	0.890	0.000
N76.4 Abscess of vulva	0.107	0.893	0.000
N70-N77 Inflammatory diseases of female pelvic organs	0.106	0.894	0.000
N76.2 Acute vulvitis	0.098	0.902	0.000
N72 Inflammatory disease of cervix uteri	0.098	0.902	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.903	0.097
N76.6 Ulceration of vulva	0.092	0.908	0.000
N76.8 Other specified inflammation of vagina and vulva	0.089	0.911	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.088	0.912	0.000
N76.3 Subacute and chronic vulvitis	0.086	0.914	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.086	0.914	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.085	0.915	0.000
N76.5 Ulceration of vagina	0.078	0.922	0.000
N76.1 Subacute and chronic vaginitis	0.078	0.922	0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere	0.076	0.924	0.000
N76.0 Acute vaginitis	0.076	0.924	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.070	0.930	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.070	0.930	0.000
N70.0 Acute salpingitis and oophoritis	0.067	0.933	0.000
N73 Other female pelvic inflammatory diseases	0.067	0.933	0.000
Q80-Q89 Other congenital malformations	0.061	0.939	0.000
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere	0.061	0.939	0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere	0.061	0.939	0.000
T42.1 Iminostilbenes	0.059	0.941	0.000
Q63 Other congenital malformations of kidney	0.059	0.941	0.000
Q63.0 Accessory kidney	0.059	0.941	0.000
Q89 Other congenital malformations, not elsewhere classified	0.059	0.941	0.000
Q60-Q64 Congenital malformations of the urinary system	0.058	0.942	0.000
Q89.2 Congenital malformations of other endocrine glands	0.057	0.943	0.000
T42.4 Benzodiazepines	0.057	0.943	0.000
N73.0 Acute parametritis and pelvic cellulitis	0.057	0.943	0.000
N74.8 Female pelvic inflammatory disorders in other diseases classified elsewhere	0.055	0.945	0.000
N74.4 Female chlamydial pelvic inflammatory disease	0.055	0.945	0.000
N74.3 Female gonococcal pelvic inflammatory disease	0.055	0.945	0.000
N74.2 Female syphilitic pelvic inflammatory disease	0.055	0.945	0.000
N74.1 Female tuberculous pelvic inflammatory disease	0.055	0.945	0.000
N74.0 Tuberculous infection of cervix uteri	0.055	0.945	0.000
N73.1 Chronic parametritis and pelvic cellulitis	0.055	0.945	0.000
Q83 Congenital malformations of breast	0.055	0.945	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.054	0.946	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.053	0.947	0.000
Q82 Other congenital malformations of skin	0.053	0.947	0.000
N75 Diseases of Bartholin's gland	0.053	0.947	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.052	0.948	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.050	0.950	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.050	0.950	0.000
T42.2 Succinimides and oxazolidinediones	0.050	0.950	0.000
T42.3 Barbiturates	0.049	0.951	0.000
N73.8 Other specified female pelvic inflammatory diseases	0.049	0.951	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.049	0.951	0.000
N73.4 Female chronic pelvic peritonitis	0.048	0.952	0.000
N73.3 Female acute pelvic peritonitis	0.048	0.952	0.000
N73.2 Unspecified parametritis and pelvic cellulitis	0.048	0.952	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.048	0.952	0.000
Q85 Phakomatoses, not elsewhere classified	0.047	0.953	0.000
Q82.5 Congenital nonneoplastic naevus	0.047	0.953	0.000
Q61 Cystic kidney disease	0.046	0.954	0.000
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.045	0.955	0.000
N73.5 Female pelvic peritonitis, unspecified	0.045	0.955	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.045	0.955	0.000
Q83.8 Other congenital malformations of breast	0.045	0.955	0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.045	0.955	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.045	0.955	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.044	0.956	0.000
Q84 Other congenital malformations of integument	0.044	0.956	0.000
Q81 Epidermolysis bullosa	0.044	0.956	0.000
Q80 Congenital ichthyosis	0.044	0.956	0.000
Q83.1 Accessory breast	0.044	0.956	0.000
Q83.3 Accessory nipple	0.044	0.956	0.000
Q82.2 Mastocytosis	0.044	0.956	0.000
N75.8 Other diseases of Bartholin's gland	0.043	0.957	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.043	0.957	0.000
Q79.6 Ehlers-Danlos syndrome	0.043	0.957	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.043	0.957	0.000
Q63.2 Ectopic kidney	0.043	0.957	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.043	0.957	0.000
Q63.8 Other specified congenital malformations of kidney	0.043	0.957	0.000
Q63.3 Hyperplastic and giant kidney	0.043	0.957	0.000
Q64 Other congenital malformations of urinary system	0.043	0.957	0.000
Q89.9 Congenital malformation, unspecified	0.042	0.958	0.000
Q89.8 Other specified congenital malformations	0.042	0.958	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.042	0.958	0.000
Q89.4 Conjoined twins	0.042	0.958	0.000
Q89.3 Situs inversus	0.042	0.958	0.000
Q89.1 Congenital malformations of adrenal gland	0.042	0.958	0.000
Q89.0 Congenital malformations of spleen	0.042	0.958	0.000
T42.0 Hydantoin derivatives	0.042	0.958	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.041	0.959	0.000
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.040	0.960	0.000
Q87.4 Marfan's syndrome	0.040	0.960	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.040	0.960	0.000
Q35-Q37 Cleft lip and cleft palate	0.040	0.960	0.000
Q62.5 Duplication of ureter	0.040	0.960	0.000
Q83.9 Congenital malformation of breast, unspecified	0.039	0.960	0.000
Q83.2 Absent nipple	0.039	0.960	0.000
Q83.0 Congenital absence of breast with absent nipple	0.039	0.960	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.039	0.961	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.038	0.962	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.038	0.962	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.038	0.962	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.038	0.962	0.000
Q61.5 Medullary cystic kidney	0.038	0.962	0.000
Q79.8 Other congenital malformations of musculoskeletal system	0.038	0.962	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.038	0.962	0.000
Q82.9 Congenital malformation of skin, unspecified	0.038	0.962	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.038	0.962	0.000
Q82.3 Incontinentia pigmenti	0.038	0.962	0.000
Q82.1 Xeroderma pigmentosum	0.038	0.962	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.038	0.962	0.000
Q61.0 Congenital single renal cyst	0.038	0.962	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.038	0.962	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.038	0.962	0.000
N71 Inflammatory disease of uterus, except cervix	0.038	0.962	0.000
Q40 Other congenital malformations of upper alimentary tract	0.037	0.963	0.000
Q85.9 Phakomatosis, unspecified	0.037	0.963	0.000
Q67 Congenital musculoskeletal deformities of head, face, spine and chest	0.037	0.963	0.000
Q50-Q56 Congenital malformations of genital organs	0.036	0.964	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.036	0.964	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.036	0.964	0.000
Q43 Other congenital malformations of intestine	0.035	0.965	0.000
Q82.0 Hereditary lymphoedema	0.035	0.965	0.000
Q62.8 Other congenital malformations of ureter	0.035	0.965	0.000
Q62.7 Congenital vesico-uretero-renal reflux	0.035	0.965	0.000
Q62.6 Malposition of ureter	0.035	0.965	0.000
Q62.4 Agenesis of ureter	0.035	0.965	0.000
Q62.2 Congenital megaloureter	0.035	0.965	0.000
Q62.1 Atresia and stenosis of ureter	0.035	0.965	0.000
Q62.0 Congenital hydronephrosis	0.035	0.965	0.000
Q45 Other congenital malformations of digestive system	0.035	0.965	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.035	0.965	0.000
Q31 Congenital malformations of larynx	0.034	0.966	0.000
Q85.1 Tuberous sclerosis	0.034	0.966	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.034	0.966	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.034	0.966	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.034	0.966	0.000
Q82.8 Other specified congenital malformations of skin	0.034	0.966	0.000
Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine	0.034	0.966	0.000
Q60.2 Renal agenesis, unspecified	0.034	0.966	0.000
Q61.3 Polycystic kidney, unspecified	0.034	0.966	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.033	0.966	0.000
Q68 Other congenital musculoskeletal deformities	0.033	0.967	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.033	0.967	0.000
Q40.2 Other specified congenital malformations of stomach	0.033	0.967	0.000
Q61.8 Other cystic kidney diseases	0.033	0.967	0.000
Q61.4 Renal dysplasia	0.033	0.967	0.000
Q61.1 Polycystic kidney, infantile type	0.033	0.967	0.000
Q75 Other congenital malformations of skull and face bones	0.033	0.967	0.000
Q73 Reduction defects of unspecified limb	0.033	0.967	0.000
Q72 Reduction defects of lower limb	0.033	0.967	0.000
Q71 Reduction defects of upper limb	0.033	0.967	0.000
Q70 Syndactyly	0.033	0.967	0.000
Q69 Polydactyly	0.033	0.967	0.000
T43.6 Psychostimulants with abuse potential	0.033	0.967	0.000
Q79.9 Congenital malformation of musculoskeletal system, unspecified	0.032	0.968	0.000
Q79.5 Other congenital malformations of abdominal wall	0.032	0.968	0.000
Q79.4 Prune belly syndrome	0.032	0.968	0.000
Q79.3 Gastroschisis	0.032	0.968	0.000
Q79.2 Exomphalos	0.032	0.968	0.000
Q79.1 Other congenital malformations of diaphragm	0.032	0.968	0.000
Q79.0 Congenital diaphragmatic hernia	0.032	0.968	0.000
S32.10 Fracture of sacrum (closed)	0.032	0.968	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.032	0.968	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.032	0.968	0.000
Q80.9 Congenital ichthyosis, unspecified	0.032	0.968	0.000
Q80.8 Other congenital ichthyosis	0.032	0.968	0.000
Q80.4 Harlequin foetus	0.032	0.968	0.000
Q80.3 Congenital bullous ichthyosiform erythroderma	0.032	0.968	0.000
Q80.2 Lamellar ichthyosis	0.032	0.968	0.000
Q80.1 X-linked ichthyosis	0.032	0.968	0.000
Q80.0 Ichthyosis vulgaris	0.032	0.968	0.000
Q81.9 Epidermolysis bullosa, unspecified	0.032	0.968	0.000
Q81.8 Other epidermolysis bullosa	0.032	0.968	0.000
Q81.2 Epidermolysis bullosa dystrophica	0.032	0.968	0.000
Q81.1 Epidermolysis bullosa letalis	0.032	0.968	0.000
Q81.0 Epidermolysis bullosa simplex	0.032	0.968	0.000
Q84.9 Congenital malformation of integument, unspecified	0.032	0.968	0.000
Q84.8 Other specified congenital malformations of integument	0.032	0.968	0.000
Q84.6 Other congenital malformations of nails	0.032	0.968	0.000
Q84.5 Enlarged and hypertrophic nails	0.032	0.968	0.000
Q84.4 Congenital leukonychia	0.032	0.968	0.000
Q84.3 Anonychia	0.032	0.968	0.000
Q84.2 Other congenital malformations of hair	0.032	0.968	0.000
Q84.1 Congenital morphological disturbances of hair, not elsewhere classified	0.032	0.968	0.000
Q84.0 Congenital alopecia	0.032	0.968	0.000
Q86.8 Other congenital malformation syndromes due to known exogenous causes	0.032	0.968	0.000
Q86.2 Dysmorphism due to warfarin	0.032	0.968	0.000
Q86.1 Foetal hydantoin syndrome	0.032	0.968	0.000
Q86.0 Foetal alcohol syndrome (dysmorphic)	0.032	0.968	0.000
Q00-Q07 Congenital malformations of the nervous system	0.032	0.968	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.032	0.968	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.032	0.968	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.032	0.968	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.031	0.969	0.000
Q53 Undescended testicle	0.031	0.969	0.000
Q78 Other osteochondrodysplasias	0.031	0.969	0.000
Q42 Congenital absence, atresia and stenosis of large intestine	0.031	0.969	0.000
Q41 Congenital absence, atresia and stenosis of small intestine	0.031	0.969	0.000
Q67.4 Other congenital deformities of skull, face and jaw	0.031	0.969	0.000
T40.2 Other opioids	0.031	0.969	0.000
Q30 Congenital malformations of nose	0.031	0.969	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.031	0.969	0.000
Z82.4 Family history of ischaemic heart disease and other diseases of the circulatory system	0.000	0.969	0.031
T36 Poisoning by systemic antibiotics	0.031	0.969	0.000
Q34 Other congenital malformations of respiratory system	0.031	0.969	0.000
Q33 Congenital malformations of lung	0.031	0.969	0.000
Q32 Congenital malformations of trachea and bronchus	0.031	0.969	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.031	0.969	0.000
Q64.8 Other specified congenital malformations of urinary system	0.031	0.969	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.031	0.969	0.000
Q64.6 Congenital diverticulum of bladder	0.031	0.969	0.000
Q64.5 Congenital absence of bladder and urethra	0.031	0.969	0.000
Q64.4 Malformation of urachus	0.031	0.969	0.000
Q64.2 Congenital posterior urethral valves	0.031	0.969	0.000
Q64.1 Exstrophy of urinary bladder	0.031	0.969	0.000
Q64.0 Epispadias	0.031	0.969	0.000
T43.9 Psychotropic drug, unspecified	0.030	0.970	0.000
Q45.3 Other congenital malformations of pancreas and pancreatic duct	0.030	0.970	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.030	0.970	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.030	0.970	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.030	0.970	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.029	0.970	0.000
Q52 Other congenital malformations of female genitalia	0.029	0.970	0.000
Q37 Cleft palate with cleft lip	0.029	0.971	0.000
Q60.6 Potter's syndrome	0.029	0.971	0.000
Q60.5 Renal hypoplasia, unspecified	0.029	0.971	0.000
Q60.4 Renal hypoplasia, bilateral	0.029	0.971	0.000
Q60.3 Renal hypoplasia, unilateral	0.029	0.971	0.000
Q60.1 Renal agenesis, bilateral	0.029	0.971	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.029	0.971	0.000
Q36 Cleft lip	0.029	0.971	0.000
Q35 Cleft palate	0.029	0.971	0.000
Z03.1 Observation for suspected malignant neoplasm	0.000	0.972	0.028
Q43.0 Meckel's diverticulum	0.028	0.972	0.000
Q43.1 Hirschsprung's disease	0.028	0.972	0.000
Q31.0 Web of larynx	0.027	0.972	0.000
S32.1 Fracture of sacrum	0.027	0.972	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.027	0.973	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.027	0.973	0.000
Q53.1 Undescended testicle, unilateral	0.027	0.973	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.027	0.973	0.000
Q66 Congenital deformities of feet	0.027	0.973	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.027	0.973	0.000
Q61.2 Polycystic kidney, adult type	0.027	0.973	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.027	0.973	0.000
Q40.9 Congenital malformation of upper alimentary tract, unspecified	0.027	0.973	0.000
Q40.8 Other specified congenital malformations of upper alimentary tract	0.027	0.973	0.000
Q40.3 Congenital malformation of stomach, unspecified	0.027	0.973	0.000
Q40.1 Congenital hiatus hernia	0.027	0.973	0.000
Q40.0 Congenital hypertrophic pyloric stenosis	0.027	0.973	0.000
Q39 Congenital malformations of oesophagus	0.027	0.973	0.000
Q65 Congenital deformities of hip	0.027	0.973	0.000
Q61.9 Cystic kidney disease, unspecified	0.026	0.973	0.000
Q67.8 Other congenital deformities of chest	0.026	0.973	0.000
Q67.7 Pectus carinatum	0.026	0.973	0.000
Q67.3 Plagiocephaly	0.026	0.973	0.000
Q67.2 Dolichocephaly	0.026	0.973	0.000
Q67.1 Compression facies	0.026	0.973	0.000
Q67.0 Facial asymmetry	0.026	0.973	0.000
T43.2 Other and unspecified antidepressants	0.027	0.973	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.026	0.974	0.000
Q67.5 Congenital deformity of spine	0.026	0.974	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.026	0.974	0.000
T40.8 Lysergide [LSD]	0.026	0.974	0.000
T40.7 Cannabis (derivatives)	0.026	0.974	0.000
T40.5 Cocaine	0.026	0.974	0.000
T40.3 Methadone	0.026	0.974	0.000
T40.1 Heroin	0.026	0.974	0.000
T40.0 Opium	0.026	0.974	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.026	0.974	0.000
T48.5 Anti-common-cold drugs	0.026	0.974	0.000
T48.4 Expectorants	0.026	0.974	0.000
T48.3 Antitussives	0.026	0.974	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.026	0.974	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.026	0.974	0.000
T48.0 Oxytocic drugs	0.026	0.974	0.000
Q76 Congenital malformations of spine and bony thorax	0.026	0.974	0.000
Q31.3 Laryngocele	0.026	0.974	0.000
Q43.9 Congenital malformation of intestine, unspecified	0.026	0.974	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.026	0.974	0.000
Q74 Other congenital malformations of limb(s)	0.025	0.974	0.000
T38.0 Glucocorticoids and synthetic analogues	0.026	0.974	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.026	0.974	0.000
Q67.6 Pectus excavatum	0.025	0.974	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.025	0.974	0.000
Q43.7 Persistent cloaca	0.025	0.974	0.000
Q43.6 Congenital fistula of rectum and anus	0.025	0.974	0.000
Q43.5 Ectopic anus	0.025	0.974	0.000
Q43.4 Duplication of intestine	0.025	0.974	0.000
Q43.2 Other congenital functional disorders of colon	0.025	0.974	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.025	0.975	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.025	0.975	0.000
T40.6 Other and unspecified narcotics	0.025	0.975	0.000
Q77.4 Achondroplasia	0.025	0.975	0.000
Q45.9 Congenital malformation of digestive system, unspecified	0.025	0.975	0.000
Q45.2 Congenital pancreatic cyst	0.025	0.975	0.000
Q45.1 Annular pancreas	0.025	0.975	0.000
Q45.0 Agenesis, aplasia and hypoplasia of pancreas	0.025	0.975	0.000
N75.0 Cyst of Bartholin's gland	0.025	0.975	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.025	0.975	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.025	0.975	0.000
T46.7 Peripheral vasodilators	0.025	0.975	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.025	0.975	0.000
Q43.3 Congenital malformations of intestinal fixation	0.025	0.975	0.000
Q31.9 Congenital malformation of larynx, unspecified	0.025	0.975	0.000
Q31.8 Other congenital malformations of larynx	0.025	0.975	0.000
Q31.5 Congenital laryngomalacia	0.025	0.975	0.000
Q31.4 Congenital laryngeal stridor	0.025	0.975	0.000
Q31.2 Laryngeal hypoplasia	0.025	0.975	0.000
Q31.1 Congenital subglottic stenosis	0.025	0.975	0.000
T50.8 Diagnostic agents	0.025	0.975	0.000
Q15 Other congenital malformations of eye	0.025	0.975	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.025	0.975	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.025	0.975	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.025	0.975	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.025	0.975	0.000
T44.0 Anticholinesterase agents	0.025	0.975	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.025	0.975	0.000
Q96 Turner's syndrome	0.024	0.975	0.000
Q68.8 Other specified congenital musculoskeletal deformities	0.024	0.975	0.000
Q43.8 Other specified congenital malformations of intestine	0.025	0.975	0.000
Q99 Other chromosome abnormalities, not elsewhere classified	0.024	0.975	0.000
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified	0.024	0.975	0.000
Q95 Balanced rearrangements and structural markers, not elsewhere classified	0.024	0.975	0.000
Q93 Monosomies and deletions from the autosomes, not elsewhere classified	0.024	0.975	0.000
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified	0.024	0.975	0.000
Q91 Edwards' syndrome and Patau's syndrome	0.024	0.975	0.000
Q14 Congenital malformations of posterior segment of eye	0.024	0.975	0.000
S32.0 Fracture of lumbar vertebra	0.025	0.975	0.000
Q51 Congenital malformations of uterus and cervix	0.024	0.976	0.000
Q77.9 Osteochondrodysplasia with defects of growth of tubular bones and spine, unspecified	0.024	0.976	0.000
Q77.8 Other osteochondrodysplasia with defects of growth of tubular bones and spine	0.024	0.976	0.000
Q77.7 Spondyloepiphyseal dysplasia	0.024	0.976	0.000
Q77.6 Chondroectodermal dysplasia	0.024	0.976	0.000
Q77.5 Diastrophic dysplasia	0.024	0.976	0.000
Q77.3 Chondrodysplasia punctata	0.024	0.976	0.000
Q77.2 Short rib syndrome	0.024	0.976	0.000
Q77.1 Thanatophoric short stature	0.024	0.976	0.000
Q77.0 Achondrogenesis	0.024	0.976	0.000
Q03 Congenital hydrocephalus	0.024	0.976	0.000
T38.1 Thyroid hormones and substitutes	0.024	0.976	0.000
T50.1 Loop [high-ceiling] diuretics	0.024	0.976	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.024	0.976	0.000
T37.5 Antiviral drugs	0.024	0.976	0.000
T37.4 Anthelminthics	0.024	0.976	0.000
T37.3 Other antiprotozoal drugs	0.024	0.976	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.024	0.976	0.000
T37.1 Antimycobacterial drugs	0.024	0.976	0.000
T37.0 Sulphonamides	0.024	0.976	0.000
T40.4 Other synthetic narcotics	0.024	0.976	0.000
S32 Fracture of lumbar spine and pelvis	0.024	0.976	0.000
Q68.5 Congenital bowing of long bones of leg, unspecified	0.024	0.976	0.000
Q68.4 Congenital bowing of tibia and fibula	0.024	0.976	0.000
Q68.3 Congenital bowing of femur	0.024	0.976	0.000
Q68.2 Congenital deformity of knee	0.024	0.976	0.000
Q68.1 Congenital deformity of hand	0.024	0.976	0.000
Q68.0 Congenital deformity of sternocleidomastoid muscle	0.024	0.976	0.000
T50.4 Drugs affecting uric acid metabolism	0.024	0.976	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.000	0.976	0.024
Q16 Congenital malformations of ear causing impairment of hearing	0.024	0.976	0.000
Q13 Congenital malformations of anterior segment of eye	0.024	0.976	0.000
Q11 Anophthalmos, microphthalmos and macrophthalmos	0.024	0.976	0.000
N73.6 Female pelvic peritoneal adhesions	0.024	0.976	0.000
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.024	0.976	0.000
Q18 Other congenital malformations of face and neck	0.024	0.976	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.024	0.976	0.000
Q69.9 Polydactyly, unspecified	0.024	0.976	0.000
Q69.2 Accessory toe(s)	0.024	0.976	0.000
Q69.1 Accessory thumb(s)	0.024	0.976	0.000
Q69.0 Accessory finger(s)	0.024	0.976	0.000
Q70.9 Syndactyly, unspecified	0.024	0.976	0.000
Q70.4 Polysyndactyly	0.024	0.976	0.000
Q70.3 Webbed toes	0.024	0.976	0.000
Q70.2 Fused toes	0.024	0.976	0.000
Q70.1 Webbed fingers	0.024	0.976	0.000
Q70.0 Fused fingers	0.024	0.976	0.000
Q71.9 Reduction defect of upper limb, unspecified	0.024	0.976	0.000
Q71.8 Other reduction defects of upper limb(s)	0.024	0.976	0.000
Q71.6 Lobster-claw hand	0.024	0.976	0.000
Q71.5 Longitudinal reduction defect of ulna	0.024	0.976	0.000
Q71.4 Longitudinal reduction defect of radius	0.024	0.976	0.000
Q71.3 Congenital absence of hand and finger(s)	0.024	0.976	0.000
Q71.2 Congenital absence of both forearm and hand	0.024	0.976	0.000
Q71.1 Congenital absence of upper arm and forearm with hand present	0.024	0.976	0.000
Q71.0 Congenital complete absence of upper limb(s)	0.024	0.976	0.000
Q72.9 Reduction defect of lower limb, unspecified	0.024	0.976	0.000
Q72.8 Other reduction defects of lower limb(s)	0.024	0.976	0.000
Q72.7 Split foot	0.024	0.976	0.000
Q72.6 Longitudinal reduction defect of fibula	0.024	0.976	0.000
Q72.5 Longitudinal reduction defect of tibia	0.024	0.976	0.000
Q72.4 Longitudinal reduction defect of femur	0.024	0.976	0.000
Q72.3 Congenital absence of foot and toe(s)	0.024	0.976	0.000
Q72.2 Congenital absence of both lower leg and foot	0.024	0.976	0.000
Q72.1 Congenital absence of thigh and lower leg with foot present	0.024	0.976	0.000
Q72.0 Congenital complete absence of lower limb(s)	0.024	0.976	0.000
Q73.8 Other reduction defects of unspecified limb(s)	0.024	0.976	0.000
Q73.1 Phocomelia, unspecified limb(s)	0.024	0.976	0.000
Q73.0 Congenital absence of unspecified limb(s)	0.024	0.976	0.000
Q75.9 Congenital malformation of skull and face bones, unspecified	0.024	0.976	0.000
Q75.8 Other specified congenital malformations of skull and face bones	0.024	0.976	0.000
Q75.5 Oculomandibular dysostosis	0.024	0.976	0.000
Q75.4 Mandibulofacial dysostosis	0.024	0.976	0.000
Q75.3 Macrocephaly	0.024	0.976	0.000
Q75.2 Hypertelorism	0.024	0.976	0.000
Q75.1 Craniofacial dysostosis	0.024	0.976	0.000
Q75.0 Craniosynostosis	0.024	0.976	0.000
Q53.2 Undescended testicle, bilateral	0.023	0.976	0.000
Q52.1 Doubling of vagina	0.023	0.976	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.023	0.977	0.000
Q55 Other congenital malformations of male genital organs	0.023	0.977	0.000
T41.5 Therapeutic gases	0.023	0.977	0.000
T41.4 Anaesthetic, unspecified	0.023	0.977	0.000
T41.3 Local anaesthetics	0.023	0.977	0.000
T41.2 Other and unspecified general anaesthetics	0.023	0.977	0.000
T41.1 Intravenous anaesthetics	0.023	0.977	0.000
T41.0 Inhaled anaesthetics	0.023	0.977	0.000
T49.9 Topical agent, unspecified	0.023	0.977	0.000
T49.8 Other topical agents	0.023	0.977	0.000
T49.7 Dental drugs, topically applied	0.023	0.977	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.023	0.977	0.000
T49.5 Ophthalmological drugs and preparations	0.023	0.977	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.023	0.977	0.000
T49.3 Emollients, demulcents and protectants	0.023	0.977	0.000
T49.2 Local astringents and local detergents	0.023	0.977	0.000
T49.1 Antipruritics	0.023	0.977	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.023	0.977	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.023	0.977	0.000
Q45.8 Other specified congenital malformations of digestive system	0.023	0.977	0.000
Q06 Other congenital malformations of spinal cord	0.023	0.977	0.000
Q01 Encephalocele	0.023	0.977	0.000
Q00 Anencephaly and similar malformations	0.023	0.977	0.000
Q02 Microcephaly	0.023	0.977	0.000
T38.9 Other and unspecified hormone antagonists	0.023	0.977	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.023	0.977	0.000
T38.7 Androgens and anabolic congeners	0.023	0.977	0.000
T38.5 Other oestrogens and progestogens	0.023	0.977	0.000
T38.4 Oral contraceptives	0.023	0.977	0.000
T38.2 Antithyroid drugs	0.023	0.977	0.000
Q52.5 Fusion of labia	0.023	0.977	0.000
T39.4 Antirheumatics, not elsewhere classified	0.023	0.977	0.000
T39.2 Pyrazolone derivatives	0.023	0.977	0.000
Q30.3 Congenital perforated nasal septum	0.023	0.977	0.000
Q53.9 Undescended testicle, unspecified	0.023	0.977	0.000
Q53.0 Ectopic testis	0.023	0.977	0.000
Q78.9 Osteochondrodysplasia, unspecified	0.023	0.977	0.000
Q78.8 Other specified osteochondrodysplasias	0.023	0.977	0.000
Q78.6 Multiple congenital exostoses	0.023	0.977	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations